Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...

A team of researchers from the Ministry of Health in Kuwait has successfully demonstrated the destruction of SARS-CoV-2 virus ...

Scientists are closely watching SARS-CoV-2 to track mutations and see if it's developed into different strains. So, has it?

Researchers think the virus behind COVID-19 may have multiple ways into cells—which could help us understand how it behaves.

Researchers from the Ministry of Health in Kuwait have demonstrated that high-frequency sound waves can functionally inactivate SARS-CoV-2, offering ...

Multiple randomized clinical trials and health record studies show that taking metformin during or soon after SARS-CoV-2 infection lowers the risk of long COVID. This makes metformin the first ...

Mounting evidence points to a link between new-onset allergies and Long COVID, with mast cell activation syndrome as a ...

The Phase I/II study will enrol approximately 368 adults aged 18 years and above.

The BNT162b2 KP.2 vaccine effectively prevents severe COVID-19 outcomes, including hospitalizations and ED or UC visits.

SK bioscience announced the initiation of a global Phase 1/2 clinical trial in Australia for GBP511, a vaccine candidate ...